# Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes

> **NCT01483352** · NA · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Accu-Chek DiaPort

## Key facts

- **NCT ID:** NCT01483352
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01483352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01483352, "Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01483352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*